NIMH Research Funding Opportunities- May 5, 2017

National Institute of Mental Health sent this bulletin at 05/05/2017 04:59 PM EDT

Research Funding Banner

NIMH Research Funding Opportunities

May 5, 2017

LATEST POLICY ANNOUNCEMENTS and NOTICES Relevant to NIMH’s mission- http://www.nimh.nih.gov/funding/index.shtml

 

Notices

  • Notice of Correction to PAR-17-179 " From Genomic Association to Causation: A Convergent Neuroscience Approach for Integrating Levels of Analysis to Delineate Brain Function in Neuropsychiatry (U01)" (NOT-MH-17-021) National Institute of Mental Health
  • Notice of Correction to PAR-17-176 "From Genomic Association to Causation: A Convergent Neuroscience Approach for Integrating Levels of Analysis to Delineate Brain Function in Neuropsychiatry (Collaborative U01)" (NOT-MH-17-022) National Institute of Mental Health
  • Notice of Clarification of Application Due Dates for RFA-OD-17-005 "Intensive Longitudinal Analysis of Health Behaviors: Leveraging New Technologies to Understand Health Behaviors (U24) (NOT-OD-17-061) Office of Behavioral and Social Science Research National Cancer Institute National Institute on Alcohol Abuse and Alcoholism National Institute of Biomedical Imaging and Bioengineering National Institute on Drug Abuse National Institute of Mental Health
  • New "FORMS-E" Grant Application Forms and Instructions Coming for Due Dates On or After January 25, 2018 (NOT-OD-17-062) National Institutes of Health

 

Requests for Applications 

  • Role of Myeloid Cells in Persistence and Eradication of HIV-1 Reservoirs from the Brain (R01) (RFA-MH-18-300) National Institute of Mental Health National Institute on Drug Abuse National Institute of Neurological Disorders and Stroke Application Receipt Date(s): September 6, 2017, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.

  • Role of Myeloid Cells in Persistence and Eradication of HIV-1 Reservoirs from the Brain (R21) (RFA-MH-18-301) National Institute of Mental Health National Institute on Drug Abuse National Institute of Neurological Disorders and Stroke Application Receipt Date(s): September 6, 2017, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.

  • Revision Applications for Regenerative Medicine Innovation Projects (RMIP) (R43/R44) (RFA-HL-17-023) National Heart, Lung, and Blood Institute National Center for Advancing Translational Sciences National Eye Institute National Institute on Aging National Institute of Allergy and Infectious Diseases National Institute of Arthritis and Musculoskeletal and Skin Diseases National Institute of Biomedical Imaging and Bioengineering National Institute on Deafness and Other Communication Disorders National Institute of Dental and Craniofacial Research National Institute of Diabetes and Digestive and Kidney Diseases National Institute of Mental Health National Institute of Neurological Disorders and Stroke Application Receipt Date(s): June 26, 2017, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date.

  • Revision Applications for Regenerative Medicine Innovation Projects (RMIP) (R41/R42) (RFA-HL-17-024) National Heart, Lung, and Blood Institute National Center for Advancing Translational Sciences National Eye Institute National Institute on Aging National Institute of Allergy and Infectious Diseases National Institute of Arthritis and Musculoskeletal and Skin Diseases National Institute of Biomedical Imaging and Bioengineering National Institute on Deafness and Other Communication Disorders National Institute of Dental and Craniofacial Research National Institute of Diabetes and Digestive and Kidney Diseases National Institute of Mental Health National Institute of Neurological Disorders and Stroke Application Receipt Date(s): June 26, 2017, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date.

  • Revision Applications for Regenerative Medicine Innovation Projects (RMIP) (U54) (RFA-HL-17-025) National Heart, Lung, and Blood Institute National Center for Advancing Translational Sciences National Eye Institute National Institute on Aging National Institute of Allergy and Infectious Diseases National Institute of Arthritis and Musculoskeletal and Skin Diseases National Institute of Biomedical Imaging and Bioengineering National Institute on Deafness and Other Communication Disorders National Institute of Dental and Craniofacial Research National Institute of Diabetes and Digestive and Kidney Diseases National Institute of Mental Health National Institute of Neurological Disorders and Stroke Application Receipt Date(s): June 26, 2017, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date.

  • Revision Applications for Regenerative Medicine Innovation Projects (RMIP) (UM1) (RFA-HL-17-026) National Heart, Lung, and Blood Institute National Center for Advancing Translational Sciences National Eye Institute National Institute on Aging National Institute of Allergy and Infectious Diseases National Institute of Arthritis and Musculoskeletal and Skin Diseases National Institute of Biomedical Imaging and Bioengineering National Institute on Deafness and Other Communication Disorders National Institute of Dental and Craniofacial Research National Institute of Diabetes and Digestive and Kidney Diseases National Institute of Mental Health National Institute of Neurological Disorders and Stroke Application Receipt Date(s): June 26, 2017, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date.

  • Revision Applications for Regenerative Medicine Innovation Projects (RMIP) (UC4) (RFA-HL-17-027) National Heart, Lung, and Blood Institute National Center for Advancing Translational Sciences National Eye Institute National Institute on Aging National Institute of Allergy and Infectious Diseases National Institute of Arthritis and Musculoskeletal and Skin Diseases National Institute of Biomedical Imaging and Bioengineering National Institute on Deafness and Other Communication Disorders National Institute of Dental and Craniofacial Research National Institute of Diabetes and Digestive and Kidney Diseases National Institute of Mental Health National Institute of Neurological Disorders and Stroke Application Receipt Date(s): June 26, 2017, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date.

  • Revision Applications for Regenerative Medicine Innovation Projects (RMIP) (U24) (RFA-HL-17-028) National Heart, Lung, and Blood Institute National Center for Advancing Translational Sciences National Eye Institute National Institute on Aging National Institute of Allergy and Infectious Diseases National Institute of Arthritis and Musculoskeletal and Skin Diseases National Institute of Biomedical Imaging and Bioengineering National Institute on Deafness and Other Communication Disorders National Institute of Dental and Craniofacial Research National Institute of Diabetes and Digestive and Kidney Diseases National Institute of Mental Health National Institute of Neurological Disorders and Stroke Application Receipt Date(s): June 26, 2017, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date.

  • Revision Applications for Regenerative Medicine Innovation Projects (RMIP) (R01) (RFA-HL-17-029) National Heart, Lung, and Blood Institute National Center for Advancing Translational Sciences National Eye Institute National Institute on Aging National Institute of Allergy and Infectious Diseases National Institute of Arthritis and Musculoskeletal and Skin Diseases National Institute of Biomedical Imaging and Bioengineering National Institute on Deafness and Other Communication Disorders National Institute of Dental and Craniofacial Research National Institute of Diabetes and Digestive and Kidney Diseases National Institute of Mental Health National Institute of Neurological Disorders and Stroke Application Receipt Date(s): June 26, 2017, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date.

  • Revision Applications for Regenerative Medicine Innovation Projects (RMIP) (R24) (RFA-HL-17-030) National Heart, Lung, and Blood Institute National Center for Advancing Translational Sciences National Eye Institute National Institute on Aging National Institute of Allergy and Infectious Diseases National Institute of Arthritis and Musculoskeletal and Skin Diseases National Institute of Biomedical Imaging and Bioengineering National Institute on Deafness and Other Communication Disorders National Institute of Dental and Craniofacial Research National Institute of Diabetes and Digestive and Kidney Diseases National Institute of Mental Health National Institute of Neurological Disorders and Stroke Application Receipt Date(s): June 26, 2017, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date.

  • Revision Applications for Regenerative Medicine Innovation Projects (RMIP) (UM2) (RFA-HL-17-031) National Heart, Lung, and Blood Institute National Center for Advancing Translational Sciences National Eye Institute National Institute on Aging National Institute of Allergy and Infectious Diseases National Institute of Arthritis and Musculoskeletal and Skin Diseases National Institute of Biomedical Imaging and Bioengineering National Institute on Deafness and Other Communication Disorders National Institute of Dental and Craniofacial Research National Institute of Diabetes and Digestive and Kidney Diseases National Institute of Mental Health National Institute of Neurological Disorders and Stroke Application Receipt Date(s): June 26, 2017, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date.

  • Revision Applications for Regenerative Medicine Innovation Projects (RMIP) (P50) (RFA-HL-17-032) National Heart, Lung, and Blood Institute National Center for Advancing Translational Sciences National Eye Institute National Institute on Aging National Institute of Allergy and Infectious Diseases National Institute of Arthritis and Musculoskeletal and Skin Diseases National Institute of Biomedical Imaging and Bioengineering National Institute on Deafness and Other Communication Disorders National Institute of Dental and Craniofacial Research National Institute of Diabetes and Digestive and Kidney Diseases National Institute of Mental Health National Institute of Neurological Disorders and Stroke Application Receipt Date(s): June 26, 2017, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date.

  • Revision Applications for Regenerative Medicine Innovation Projects (RMIP) (P41) (RFA-HL-17-033) National Heart, Lung, and Blood Institute National Center for Advancing Translational Sciences National Eye Institute National Institute on Aging National Institute of Allergy and Infectious Diseases National Institute of Arthritis and Musculoskeletal and Skin Diseases National Institute of Biomedical Imaging and Bioengineering National Institute on Deafness and Other Communication Disorders National Institute of Dental and Craniofacial Research National Institute of Diabetes and Digestive and Kidney Diseases National Institute of Mental Health National Institute of Neurological Disorders and Stroke Application Receipt Date(s): June 26, 2017, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date. No late applications will be accepted for this Funding Opportunity Announcement. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.

  • Revision Applications for Regenerative Medicine Innovation Projects (RMIP) (U01) (RFA-HL-17-034) National Heart, Lung, and Blood Institute National Center for Advancing Translational Sciences National Eye Institute National Institute on Aging National Institute of Allergy and Infectious Diseases National Institute of Arthritis and Musculoskeletal and Skin Diseases National Institute of Biomedical Imaging and Bioengineering National Institute on Deafness and Other Communication Disorders National Institute of Dental and Craniofacial Research National Institute of Diabetes and Digestive and Kidney Diseases National Institute of Mental Health National Institute of Neurological Disorders and Stroke Application Receipt Date(s): June 26, 2017, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date. No late applications will be accepted for this Funding Opportunity Announcement. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.

 

Program Announcements

  • Initiation of a Mental Health Family Navigator Model to Promote Early Access, Engagement and Coordination of Needed Mental Health Services for Children and Adolescents (R01) (PAR-17-265) National Institute of Mental Health Application Receipt/Submission Date(s): Standard dates apply , by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates

  • Pilot Studies to Test the Initiation of a Mental Health Family Navigator to Promote Early Access, Engagement and Coordination of Needed Mental Health Services for Children and Adolescents (R34) (PAR-17-266) National Institute of Mental Health Application Receipt/Submission Date(s): Standard dates apply, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.

  • Pilot Effectiveness Trials for Post-Acute Interventions and Services to Optimize Longer-term Outcomes (R34) (PAR-17-271) National Institute of Mental Health Application Receipt/Submission Date(s): Standard dates apply, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.

  • Effectiveness Trials for Post-Acute Interventions and Services to Optimize Longer-term Outcomes (R01) (PAR-17-272) National Institute of Mental Health Application Receipt/Submission Date(s): Standard dates apply , by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates

  • Innovative Mental Health Services Research Not Involving Clinical Trials (R01) (PAR-17-264) National Institute of Mental Health Application Receipt/Submission Date(s): Standard dates apply , by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.

  •  

 

 

 

 

 

 

 

 

 

 

 

Considering submitting a Clinical Trial Application to NIMH.

Please be sure to review all the information provided on the NIMH Clinical Trials Funding Opportunity Announcements

 

=============

These FOAs help define NIMH’s focus on an experimental medicine approach when supporting clinical trial research.

To get more information on the data sharing expectations for NIMH funded Clinical Trials visit NOT-MH-14-015.

For information about NIMH’s Policy for the Submission of Applications containing Clinical Trials visit NOT-MH-14-007.

For a better understanding of NIMH’s policies related to Data Rigor by enhancing the reliability through design and reporting visit NOT-MH-14-004